Author:
Zhang Shengyu,Yang Jing,Jin Xiaofeng,Zhang Shuyang
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference14 articles.
1. Palumbo A, Palladino C. Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance. Ther Adv Drug Saf. 2012;3:255–66.
2. Ali A, Hothi SS, Thompson A, Malik N. Negative chronotropic effects and coronary ischaemic abnormalities following thalidomide therapy. Cardiology. 2013;125:34–7.
3. Lopez-de la Cruz I, Aguayo-Gonzalez A, Lopez-Karpovitch X. Thalidomide-associated bradycardia in patients with hematologic diseases: a single institution experience. Rev Invest Clin. 2006;58:424–31.
4. Fahdi IE, Gaddam V, Saucedo JF, Kishan CV, Vyas K, Deneke MG, et al. Bradycardia during therapy for multiple myeloma with thalidomide. Am J Cardiol. 2004;93:1052–5.
5. Hinterseer M, Becker A, Kaab S, Lang N, Nabauer M, Steinbeck G. Thalidomide-induced symptomatic third-degree atrioventricular block. Clin Res Cardiol. 2006;95:474–6.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献